Correvio Pharma Competitors and Similar CompaniesClear all

Correvio Pharma's competitors and similar companies include CSL Behring, UCB, Genentech and Mankind Pharma.

	Correvio Pharma Correvio Pharma is a specialty pharmaceutical company engaged in developing therapeutics.	CSL Behring CSL Behring is a provider of life-saving medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 2018	Founding Date 1904	Founding Date 1928	Founding Date 1976	Founding Date 1995
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Vancouver, CA HQ Puteaux, FR Genève, CH Chadds Ford, US	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations New Delhi, IN HQ
Employees	Employees 133	Employees 7,5692% decrease	Employees 9,052	Employees 18,077	Employees 16,2532% increase
Financial
Revenue (est.)	Revenue (est.) $32.6m (FY, 2019)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $9.8m (FY, 2019)	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $22.8m (FY, 2019)	Gross profit $4.5b (FY, 2020)	Gross profit €7.2b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($35.2m) (FY, 2019)	Net income N/A	Net income €1.6b (FY, 2025)	Net income N/A	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 100 (Dec, 2020)	Countries 35 (FY, 2019)	Countries N/A	Countries N/A